Plainsboro, NJ, United States of America

Vladimir Malinin

This inventor holds 23 USPTO granted patents and 37 published patent applications, plus 10 CIPO patents and 14 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Insmed Incorporated, Transave Limited. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vladimir Malinin. Retrieved from https://idiyas.com/inventor/vladimir-malinin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 87.0

 

 

Average Co-Inventor Count = 3.7

ph-index = 11

Forward Citations = 342(Granted Patents)


Location History:

  • Plainsboro, NJ (US) (2010 - 2023)
  • Bridgewater, NJ (US) (2019 - 2024)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Treprostinil Prodrugs
Prostacyclin Compounds
Lipo-Glycopeptide Derivatives
Stabilized Vancomycin
Sustained Release
Pulmonary Infections
High Potency Lipid-Based
Multicationic Drugs
Intra-Peritoneal Administration
Cancer Treatment
Drug Delivery Rates
Formulation Methods
23 patents (USPTO):Explore Patents

Title: The Innovative Mind of Vladimir Malinin

Introduction: Vladimir Malinin, based in Plainsboro, NJ, is a notable inventor with an impressive portfolio of 23 patents. His innovative contributions primarily focus on the development of pharmaceutical compositions and methods for treating various health conditions, showcasing his dedication to advancing medical science.

Latest Patents: Among Malinin's recent patents is a formulation titled "Dry powder compositions of treprostinil prodrugs and methods of use thereof." This invention provides a dry powder composition designed to treat pulmonary hypertension in patients, utilizing a novel method of inhalation via a dry powder inhaler. The formulation includes specific percentages of treprostinil prodrugs, DSPE-PEG2000, leucine, and a sugar component, all optimized for effective treatment delivery. Another noteworthy patent is for "Lipo-glycopeptide cleavable derivatives and uses thereof," which focuses on novel derivatives aimed at treating bacterial infections, emphasizing improved cellular uptake and clearance efficiency.

Career Highlights: Throughout his career, Malinin has contributed to research and development efforts at significant organizations such as Insmed Incorporated and Transave Limited. His work has consistently pushed the boundaries of pharmaceutical innovation, particularly in the field of pulmonary treatments.

Collaborations: Malinin has collaborated with esteemed colleagues, including Walter Perkins and Adam Plaunt. Their combined expertise underscores the collaborative spirit prevalent in the research community, fostering innovative solutions to complex medical challenges.

Conclusion: Vladimir Malinin's inventive spirit and commitment to pharmaceutical advancements have led to essential contributions in treating serious health conditions. His extensive patent portfolio reflects not only his individual ingenuity but also the importance of collaboration in driving innovation within the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…